Quick Answer
BIOLARGO, INC. reported Long Term Debt of $289.0 thousand for the year ending 2023.
- BIOLARGO, INC. showed an increase of +21.9% in Long Term Debt from 2022 to 2023.
- This data is from BIOLARGO, INC.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
- XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $1.24 million | Q2 2019: $210.0 thousand | Q3 2019: $700.0 thousand | Q1 2020: $700.0 thousand | Q2 2020: $949.0 thousand | Q3 2020: $507.0 thousand | Q1 2021: $481.0 thousand | Q2 2021: $485.0 thousand | Q3 2021: $489.0 thousand | Q1 2022: $150.0 thousand | Q2 2022: $247.0 thousand | Q3 2022: $247.0 thousand | Q1 2023: $302.0 thousand | Q2 2023: $299.0 thousand | Q3 2023: $293.0 thousand | Q4 2023: $289.0 thousand | Q1 2024: $284.0 thousand | Q2 2024: $184.0 thousand | Q3 2024: $180.0 thousand.
- Over the full 7 years of available data (2017 to 2023), BIOLARGO, INC.'s Long Term Debt has declined by 81.2%.
- Historical annual values: Fiscal year 2023: $289.0 thousand | Fiscal year 2022: $237.0 thousand | Fiscal year 2021: $180.0 thousand | Fiscal year 2020: $507.0 thousand | Fiscal year 2019: $700.0 thousand | Fiscal year 2018: $1.29 million | Fiscal year 2017: $1.54 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: